Portfolio Holdings Detail for ISIN IE00BMX0DF60
Stock Name / Fund iShares US Medical Devices UCITS ETF
Issuer Blackrock
Entity holding fund iShares V Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF Ticker UMDV.AS(USD) CXE
ETF Ticker UMDV(USD) Euronext Amsterdam

Holdings detail for SRDX

Stock Name	SurModics Inc
Ticker	SRDX(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US8688731004
LEI	549300H76KXCAAGUS878

Show aggregate SRDX holdings

News associated with SRDX

Surmodics (NASDAQ:SRDX) Trading 8.7% Higher on Earnings Beat: Surmodics, Inc. (NASDAQ:SRDX – Get Free Report) rose 8.7% during trading on Monday after the company announced better than expected quarterly earnings. The stock traded as high as $38.33 and last traded at $38.48. Approximately 194,800 shares traded hands during mid-day trading, an increase of 10% from the average daily volume of 176,503 shares. The […] - 2025-08-13 02:22:56
Surmodics (NASDAQ:SRDX) Receives “Market Perform” Rating from Barrington Research: Barrington Research reiterated their market perform rating on shares of Surmodics (NASDAQ:SRDX – Free Report) in a research note published on Monday,Benzinga reports. Separately, Needham & Company LLC reiterated a “hold” rating on shares of Surmodics in a research note on Wednesday, April 30th. Read Our Latest Stock Report on Surmodics Surmodics Trading Up 7.3% […] - 2025-08-12 04:47:07
Wells Fargo & Company MN Raises Holdings in Surmodics, Inc. (NASDAQ:SRDX): Wells Fargo & Company MN increased its position in shares of Surmodics, Inc. (NASDAQ:SRDX – Free Report) by 40.9% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 7,032 shares of the company’s stock after buying an additional 2,041 shares during the quarter. Wells Fargo & Company MN’s holdings in Surmodics were worth $278,000 […] - 2025-05-07 04:52:54
Marshall Wace LLP Purchases 19,635 Shares of Surmodics, Inc. (NASDAQ:SRDX): Marshall Wace LLP increased its position in Surmodics, Inc. (NASDAQ:SRDX – Free Report) by 231.0% in the 4th quarter, Holdings Channel reports. The firm owned 28,135 shares of the company’s stock after buying an additional 19,635 shares during the quarter. Marshall Wace LLP’s holdings in Surmodics were worth $1,114,000 as of its most recent filing […] - 2025-04-30 04:59:02
Barclays PLC Buys 19,251 Shares of Surmodics, Inc. (NASDAQ:SRDX): Barclays PLC grew its stake in shares of Surmodics, Inc. (NASDAQ:SRDX – Free Report) by 21.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 108,001 shares of the company’s stock after buying an additional 19,251 shares during the period. Barclays PLC […] - 2025-04-28 05:01:23
Surmodics (NASDAQ:SRDX) Upgraded at Lake Street Capital: Lake Street Capital upgraded shares of Surmodics (NASDAQ:SRDX – Free Report) from a hold rating to a buy rating in a report published on Friday morning, Marketbeat.com reports. Lake Street Capital currently has $43.00 price target on the stock. Several other equities research analysts have also recently commented on SRDX. StockNews.com started coverage on shares […] - 2025-03-10 03:56:53
New York Life Investment Management LLC Sells 2,584 Shares of Surmodics, Inc. (NASDAQ:SRDX): New York Life Investment Management LLC decreased its position in shares of Surmodics, Inc. (NASDAQ:SRDX – Free Report) by 14.1% during the fourth quarter, Holdings Channel.com reports. The fund owned 15,784 shares of the company’s stock after selling 2,584 shares during the quarter. New York Life Investment Management LLC’s holdings in Surmodics were worth $625,000 […] - 2025-03-05 08:04:59
Head to Head Comparison: Surmodics (NASDAQ:SRDX) vs. Neuronetics (NASDAQ:STIM): Neuronetics (NASDAQ:STIM – Get Free Report) and Surmodics (NASDAQ:SRDX – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, earnings, risk, valuation, institutional ownership and profitability. Analyst Ratings This is a breakdown of current ratings […] - 2025-02-11 04:52:54

iShares US Medical Devices UCITS ETF SRDX holdings

Date	Number of SRDX Shares Held	Base Market Value of SRDX Shares	Local Market Value of SRDX Shares	Change in SRDX Shares Held	Change in SRDX Base Value	Current Price per SRDX Share Held	Previous Price per SRDX Share Held
2025-09-25 (Thursday)	1,985	USD 61,178	USD 61,178
2025-09-24 (Wednesday)	1,857	USD 56,564	USD 56,564
2025-09-18 (Thursday)	1,857	USD 59,833	USD 59,833	0	USD 585	USD 32.2202	USD 31.9052
2025-09-17 (Wednesday)	1,857	USD 59,248	USD 59,248	0	USD -27	USD 31.9052	USD 31.9198
2025-09-16 (Tuesday)	1,857	USD 59,275	USD 59,275
2025-09-15 (Monday)	1,857	USD 60,111	USD 60,111
2025-09-12 (Friday)	1,857	USD 59,350	USD 59,350
2025-09-11 (Thursday)	1,857	USD 59,925	USD 59,925
2025-09-10 (Wednesday)	1,857	USD 59,647	USD 59,647

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of SRDX by Blackrock for IE00BMX0DF60

Show aggregate share trades of SRDX

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-06-27 SELL -32 28.810* 32.47 Profit of 1,039 on sale
2025-06-12 BUY 48 29.080* 32.70
2025-06-10 SELL -240 29.200* 32.75 Profit of 7,861 on sale
2025-06-09 SELL -304 29.160* 32.78 Profit of 9,965 on sale
2025-05-30 SELL -30 29.020* 32.94 Profit of 988 on sale
2025-05-19 BUY 15 29.480* 33.24
2025-05-09 SELL -90 26.760* 33.55 Profit of 3,019 on sale
2025-04-23 SELL -18 28.600* 34.18 Profit of 615 on sale
2025-04-17 SELL -18 27.570* 34.44 Profit of 620 on sale
2025-04-10 BUY 136 27.240* 34.81
2025-04-04 SELL -34 29.320* 35.12 Profit of 1,194 on sale
2025-04-02 SELL -34 30.760* 35.17 Profit of 1,196 on sale
2025-03-31 SELL -51 30.530* 35.28 Profit of 1,799 on sale
2025-03-19 SELL -16 30.000* 35.82 Profit of 573 on sale
2025-02-28 SELL -30 32.860* 37.12 Profit of 1,114 on sale
2025-02-05 BUY 54 33.850* 38.20
2025-02-04 BUY 72 33.620* 38.31
2025-01-29 SELL -17 35.775* 38.68 Profit of 658 on sale
2025-01-23 SELL -17 37.500* 38.83 Profit of 660 on sale
2025-01-02 SELL -30 39.680* 38.81 Profit of 1,164 on sale
2024-12-04 BUY 42 39.910* 38.60
2024-12-03 SELL -15 39.490* 38.56 Profit of 578 on sale
2024-12-02 SELL -180 39.610* 38.52 Profit of 6,934 on sale
2024-11-29 SELL -300 39.450* 38.49 Profit of 11,546 on sale
2024-11-27 SELL -45 39.540* 38.39 Profit of 1,728 on sale
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-06-27	SELL	-32	28.810*	32.47 Profit of 1,039 on sale
2025-06-12	BUY	48	29.080*	32.70
2025-06-10	SELL	-240	29.200*	32.75 Profit of 7,861 on sale
2025-06-09	SELL	-304	29.160*	32.78 Profit of 9,965 on sale
2025-05-30	SELL	-30	29.020*	32.94 Profit of 988 on sale
2025-05-19	BUY	15	29.480*	33.24
2025-05-09	SELL	-90	26.760*	33.55 Profit of 3,019 on sale
2025-04-23	SELL	-18	28.600*	34.18 Profit of 615 on sale
2025-04-17	SELL	-18	27.570*	34.44 Profit of 620 on sale
2025-04-10	BUY	136	27.240*	34.81
2025-04-04	SELL	-34	29.320*	35.12 Profit of 1,194 on sale
2025-04-02	SELL	-34	30.760*	35.17 Profit of 1,196 on sale
2025-03-31	SELL	-51	30.530*	35.28 Profit of 1,799 on sale
2025-03-19	SELL	-16	30.000*	35.82 Profit of 573 on sale
2025-02-28	SELL	-30	32.860*	37.12 Profit of 1,114 on sale
2025-02-05	BUY	54	33.850*	38.20
2025-02-04	BUY	72	33.620*	38.31
2025-01-29	SELL	-17	35.775*	38.68 Profit of 658 on sale
2025-01-23	SELL	-17	37.500*	38.83 Profit of 660 on sale
2025-01-02	SELL	-30	39.680*	38.81 Profit of 1,164 on sale
2024-12-04	BUY	42	39.910*	38.60
2024-12-03	SELL	-15	39.490*	38.56 Profit of 578 on sale
2024-12-02	SELL	-180	39.610*	38.52 Profit of 6,934 on sale
2024-11-29	SELL	-300	39.450*	38.49 Profit of 11,546 on sale
2024-11-27	SELL	-45	39.540*	38.39 Profit of 1,728 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of SRDX

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	25,144	10,553	64,365	39.1%
2025-09-18	17,155	0	47,640	36.0%
2025-09-17	10,184	0	58,721	17.3%
2025-09-16	10,275	0	79,664	12.9%
2025-09-15	10,231	0	45,078	22.7%
2025-09-12	9,579	0	35,153	27.2%
2025-09-11	5,775	0	26,950	21.4%
2025-09-10	12,372	0	81,713	15.1%
2025-09-09	9,000	0	86,148	10.4%
2025-09-08	9,236	0	46,207	20.0%
2025-09-05	7,629	0	31,668	24.1%
2025-09-04	21,635	0	101,877	21.2%
2025-09-03	16,586	0	51,928	31.9%
2025-09-02	28,102	0	101,377	27.7%
2025-08-29	8,912	0	38,057	23.4%
2025-08-28	4,634	0	32,754	14.1%
2025-08-27	10,250	0	88,382	11.6%
2025-08-26	17,588	0	104,000	16.9%
2025-08-25	7,655	0	32,620	23.5%
2025-08-22	45,118	1,600	378,433	11.9%
2025-08-21	53,321	8,400	252,507	21.1%
2025-08-20	49,580	0	207,734	23.9%
2025-08-19	52,902	0	240,061	22.0%
2025-08-18	17,648	0	269,467	6.5%
2025-08-15	133,385	0	226,582	58.9%
2025-08-14	33,169	0	139,098	23.8%
2025-08-13	31,628	0	105,918	29.9%
2025-08-12	25,514	0	73,902	34.5%
2025-08-11	43,738	0	132,228	33.1%
2025-08-08	13,018	0	91,003	14.3%
2025-08-07	24,177	0	63,137	38.3%
2025-08-06	17,601	0	31,009	56.8%
2025-08-05	31,676	0	61,953	51.1%
2025-08-04	55,244	0	111,956	49.3%
2025-08-01	30,753	0	61,802	49.8%
2025-07-31	33,553	0	160,196	20.9%
2025-07-30	29,048	0	87,778	33.1%
2025-07-29	34,291	0	154,528	22.2%
2025-07-28	57,621	1,517	363,975	15.8%
2025-07-25	43,681	0	150,696	29.0%
2025-07-24	6,269	0	27,758	22.6%
2025-07-23	11,321	0	41,439	27.3%
2025-07-22	8,657	0	38,382	22.6%
2025-07-21	8,914	0	17,864	49.9%
2025-07-18	7,362	0	20,306	36.3%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares US Medical Devices UCITS ETF
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	UMDV.AS(USD) CXE
ETF Ticker	UMDV(USD) Euronext Amsterdam